Catherine Calderwood is the Chief Medical Officer for Scotland, appointed in March 2015.
The Chief Medical Officer is responsible for improving the mental and physical wellbeing of people in Scotland; continuing reductions in the incidence of coronary heart disease, stroke, cancer and alcoholic liver disease; supporting improvements in the quality of healthcare; investing in research, with particular emphasis on supporting research relevant to the NHS; and taking a lead role in the ongoing measurement and interpretation of trends in health and disease.
Catherine became a medical adviser to the Scottish Government in 2010 and has been instrumental in the work in reducing stillbirths and neonatal deaths in Scotland and in reducing avoidable harm in maternity services. More recently her role expanded and work includes major trauma services and the introduction of robotic surgery for prostate cancer to Scotland.
Catherine is chair of the UK maternal, newborn and infant Clinical Outcome Review Programme. She also chairs the Scottish Government Stillbirth Working Group and is a member of the Royal College of Obstetricians and Gynaecologists Stillbirth Clinical Studies Group. She was the obstetrician on the panel of the Morecambe Bay Inquiry into maternity and neonatal services and is a member of the recently formed Review of Maternity and Neonatal Services in England.
She is an obstetrician and gynaecologist and continues to have a maternal medicine antenatal clinic at the Royal Infirmary of Edinburgh. Until her recent appointment as Chief Medical Officer Catherine was also the National Clinical Director for maternity and women's health for NHS England.
Catherine qualified from Cambridge and Glasgow universities. As a junior doctor she worked in medical specialities in Glasgow Royal infirmary and at the Royal Infirmary of Edinburgh before completing her specialist training in obstetrics and gynaecology and maternal medicine in SE Scotland and St Thomas' Hospital London.